A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223

K.M. Redmond*, P.G. Turner, A. Cole, S. Jain, K.M. Prise, J.M. O'Sullivan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

47 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science